23rd European Meeting on HIV & Hepatitis 2025

• The 23rd European Meeting on HIV & Hepatitis 2025 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 11 European CME credits (ECMEC®s). For more information, please visit the 'Accreditation' tab.

• The Standard Fee Registration Deadline ends on Friday, 4 April 2025 at 23:59 CEST. Click here for fees and conditions.

• The Abstract Submission Portal is officially closed. The reviewing process is now in progress. A final outcome is expected to be provided in the week of 24-28 March 2025.

• Accreditation and Compliant Status has been requested from the following:

  • European Accreditation Council for Continuing Medical Education (EACCME)
  • Ethical MedTech Europe

• The 23rd European Meeting on HIV & Hepatitis 2025 will be held from 4-6 June 2025 in Barcelona, Spain. For this edition of the meeting, we will be returning to the Hotel Catalonia Barcelona Plaza to host this valuable program. Please find more information regarding the location here below under "Venue".

• The enduring materials of the previous editions to this meeting are located here.

• To stay updated on the relevant developments, make sure you are signed up for our newsletter. 

It is our pleasure to confirm that the 23rd Edition of the European Meeting on HIV & Hepatitis will take place as a live meeting on 4-6 June 2025 in Barcelona, Spain.

Founded more than twenty years ago as the European HIV Resistance Workshop, the European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance has evolved to embrace all aspects of the clinical care of people living with HIV in Europe. This workshop places emphasis in particular on optimal treatment strategies, clinical virology, molecular epidemiology, and public health aspects of HIV, HBV, HCV, as well as emerging viruses throughout Europe.

In the last decade, the meeting has been able to capture leading clinicians and researchers from different regions of Europe. As such, this meeting is the only European platform where HIV-treating physicians and clinical virologists get together on an annual basis to present their latest research results and discuss their clinical implications in detail.

General Information 

Practical Information 

Registration Fees

*Countries included in the low-income and middle-income economies list of the World Bank Classification

Important

• We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.

• Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.

• The Abstract Submission Portal is officially closed. The reviewing process is now in progress. A final outcome is expected to be provided in the week of 24-28 March 2025.
   
• The European Meeting on HIV & Hepatitis 2025 accepts new original data as well as encored abstracts. All abstracts must focus on the European region and contain up-to-date information at the time of the meeting.
   
• Early-Career Investigators (ECI) or "Regular Delegate" from Resource-Limited Setting (RLS) with an accepted abstract are able to receive a 50% discount off of the early registration fee. The requirements for the application are specified here.

• Abstract submitters are strongly encouraged to use person-first language in their abstracts. View the video tutorial and guidelines here

• Abstract presenters are expected to attend the meeting in-person to present their abstract. Please contact the meeting secretariat if this is not possible.

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

Support provided by ViiV Healthcare

Supported by Gilead who provided funding.
Gilead has had no input into the content
of the materials used at this meeting.

Financial backing to the European Meeting on HIV & Hepatitis 2025 helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in HIV & Hepatitis in the European region.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.

To show your commitment to the cause, get in touch with us for a tailored support package by contacting Jesper Niesen at Jesper.Niesen@amededu.com or call +31 30 230 7140.
 
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

• Symposium opportunities
• Non-commercial interviews with company representatives
• Verbal acknowledgement during the program 
• Discounted and complimentary registrations for your representatives
• Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
• Company acknowledgement on printed meeting materials including but not limited to banners and the program book
• Digital and printed advertising opportunities 
• Social media shout-outs
• Logo on the conference bag 

 
*Subject to the support level.

The 23rd European Meeting on HIV & Hepatitis 2025 is endorsed by societies and organizations. Their support and collaboration are key to the success of this workshop. 

If you would like your organization to endorse this meeting, please contact Michelle Wu at Michelle.Wu@amededu.com for more information.

The European Meeting on HIV & Hepatitis 2025, Barcelona, Spain, 04/06/2025 - 06/06/2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 11.0 European CME credits (ECMEC®s). Each medical specialist should claim only those credits that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Join us in reliving the highlights of our past event as we look forward to welcoming you to the upcoming European Meeting on HIV & Hepatitis 2025!